🔗 Share this article

A shadow economy for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Drug Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and assertions of rapid UK delivery. Vendors market the drug there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Express Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in users administering substances of uncertain source.

Some experts said the popularity for retatrutide could be connected to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.

Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.

Platform Response and Material Removal

Based on the social media company, the service has taken down violative material and banned associated hashtags and search suggestions. The company said it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered communities with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up groups with numerous of members, populated with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at home.

Within minutes of joining one group, a vendor posted contact information, where most purchases take place. The vendor sent an guidebook and promised delivery within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, medical conditions or previous experience.

Product Details and Costs

Within these groups, posts display dark colored parcels with Royal Mail stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how long a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service stated it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her staff has already encountered patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may subject users to possibly serious medical dangers”.